27791144|t|An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb
27791144|a|The positive transcription elongation factor (P-TEFb) is required for the transcription of most genes by RNA polymerase II. Hexim proteins associated with 7SK RNA bind to P-TEFb and reversibly inhibit its activity. P-TEFb comprises the Cdk9 cyclin-dependent kinase and a cyclin T. Hexim proteins have been shown to bind the cyclin T subunit of P-TEFb. How this binding leads to inhibition of the kinase activity of Cdk9 has remained elusive, however. Using a photoreactive amino acid incorporated into proteins, we show that in live cells, cell extracts, and in vitro reconstituted complexes, Hexim1 cross-links and thus contacts Cdk9. Notably, replacement of a phenylalanine, F208, belonging to an evolutionary conserved Hexim1 peptide ((202) PYNTTQFLM (210)) known as the "PYNT" sequence, cross-links a peptide within the activation segment that controls access to the Cdk9 catalytic cleft. Reciprocally, Hexim1 is cross-linked by a photoreactive amino acid replacing Cdk9 W193, a tryptophan within this activation segment. These findings provide evidence of a direct interaction between Cdk9 and its inhibitor, Hexim1. Based on similarities with Cdk2 3D structure, the Cdk9 peptide cross-linked by Hexim1 corresponds to the substrate binding-site. Accordingly, the Hexim1 PYNT sequence is proposed to interfere with substrate binding to Cdk9 and thereby to inhibit its kinase activity.
27791144	3	40	evolutionary conserved Hexim1 peptide	T116	C1260118
27791144	41	46	binds	T044	C1167622
27791144	54	58	Cdk9	T116,T126	C0254251
27791144	59	73	catalytic site	T169	C0205681
27791144	77	84	inhibit	T052	C3463820
27791144	85	91	P-TEFb	T116,T126	C0663446
27791144	96	136	positive transcription elongation factor	T116,T126	C0663446
27791144	138	144	P-TEFb	T116,T126	C0663446
27791144	166	179	transcription	T045	C0040649
27791144	188	193	genes	T028	C0017337
27791144	197	214	RNA polymerase II	T116,T126	C0035679
27791144	216	230	Hexim proteins	T116	C1260118
27791144	231	246	associated with	T080	C0332281
27791144	263	269	P-TEFb	T116,T126	C0663446
27791144	285	292	inhibit	T052	C3463820
27791144	297	305	activity	T169	C0205177
27791144	307	313	P-TEFb	T116,T126	C0663446
27791144	328	332	Cdk9	T116,T126	C0254251
27791144	333	356	cyclin-dependent kinase	T116,T126	C0243045
27791144	363	372	cyclin T.	T116,T123	C2717923
27791144	373	387	Hexim proteins	T116	C1260118
27791144	407	411	bind	T044	C1167622
27791144	416	424	cyclin T	T116,T123	C2717923
27791144	436	442	P-TEFb	T116,T126	C0663446
27791144	453	460	binding	T044	C1167622
27791144	470	480	inhibition	T052	C3463820
27791144	488	503	kinase activity	T044	C1150423
27791144	507	511	Cdk9	T116,T126	C0254251
27791144	516	532	remained elusive	T033	C0243095
27791144	551	575	photoreactive amino acid	T116,T121,T123	C0002520
27791144	594	602	proteins	T116,T123	C0033684
27791144	620	630	live cells	T025	C0007634
27791144	632	645	cell extracts	T026	C0007592
27791144	651	659	in vitro	T080	C1533691
27791144	660	683	reconstituted complexes	T104	C1704241
27791144	685	691	Hexim1	T116	C1260118
27791144	692	703	cross-links	T169	C0332220
27791144	722	726	Cdk9	T116,T126	C0254251
27791144	737	748	replacement	T169	C0559956
27791144	754	767	phenylalanine	T116,T121,T123	C0031453
27791144	769	773	F208	T116,T121,T123	C0002520
27791144	791	828	evolutionary conserved Hexim1 peptide	T116	C1260118
27791144	836	845	PYNTTQFLM	T087	C0002518
27791144	866	881	"PYNT" sequence	T087	C0002518
27791144	883	894	cross-links	T169	C0332220
27791144	897	904	peptide	T116	C0030956
27791144	916	934	activation segment	T082	C1254362
27791144	949	955	access	T082	C0444454
27791144	963	967	Cdk9	T116,T126	C0254251
27791144	968	983	catalytic cleft	T169	C0205681
27791144	985	997	Reciprocally	T080	C1882911
27791144	999	1005	Hexim1	T116	C1260118
27791144	1009	1021	cross-linked	T169	C0332220
27791144	1027	1051	photoreactive amino acid	T116,T121,T123	C0002520
27791144	1062	1071	Cdk9 W193	T116,T126	C0254251
27791144	1075	1085	tryptophan	T116,T121,T123	C0041249
27791144	1098	1116	activation segment	T082	C1254362
27791144	1124	1132	findings	T169	C2607943
27791144	1141	1149	evidence	T078	C3887511
27791144	1155	1173	direct interaction	T044	C0872079
27791144	1182	1186	Cdk9	T116,T126	C0254251
27791144	1195	1204	inhibitor	T116,T121	C1449702
27791144	1206	1212	Hexim1	T116	C1260118
27791144	1223	1235	similarities	T080	C2348205
27791144	1241	1245	Cdk2	T116,T126	C0108855
27791144	1246	1258	3D structure	T082	C0678594
27791144	1264	1276	Cdk9 peptide	T116,T126	C0254251
27791144	1277	1289	cross-linked	T169	C0332220
27791144	1293	1299	Hexim1	T116	C1260118
27791144	1319	1341	substrate binding-site	T192	C0005456
27791144	1360	1366	Hexim1	T116	C1260118
27791144	1367	1380	PYNT sequence	T087	C0002518
27791144	1396	1410	interfere with	T169	C0521102
27791144	1411	1428	substrate binding	T044	C0033618
27791144	1432	1436	Cdk9	T116,T126	C0254251
27791144	1452	1459	inhibit	T052	C3463820
27791144	1464	1479	kinase activity	T044	C1150423